Anthony Petrone
Stock Analyst at Mizuho Securities
(4.38)
# 1,230
Out of 4,517 analysts
643
Total ratings
50.9%
Success rate
7.3%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FOCL EDAP TMS | Initiated Coverage: Buy | $15 | $5.44 | +175.74% | 1 | Jul 17, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $70 | $44.62 | +56.88% | 24 | Jul 15, 2026 | |
| DXCM DexCom | Maintained: Buy | $85 → $90 | $77.98 | +15.41% | 12 | Jul 15, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | $100 → $105 | $87.84 | +19.54% | 30 | Jul 15, 2026 | |
| HAE Haemonetics | Maintained: Buy | $85 → $90 | $78.50 | +14.65% | 70 | Jul 15, 2026 | |
| ISRG Intuitive Surgical | Maintained: Hold | $525 → $500 | $402.33 | +24.28% | 18 | Jul 15, 2026 | |
| RMD ResMed | Maintained: Buy | $235 → $220 | $202.76 | +8.50% | 31 | Jul 15, 2026 | |
| TFX Teleflex | Maintained: Hold | $140 → $145 | $135.22 | +7.23% | 22 | Jul 15, 2026 | |
| TNDM Tandem Diabetes Care | Maintained: Hold | $24 → $20 | $16.29 | +22.77% | 8 | Jul 15, 2026 | |
| LNTH Lantheus Holdings | Maintained: Buy | $115 → $120 | $105.11 | +14.17% | 36 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $17 | $8.81 | +92.96% | 34 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $95 | $81.79 | +16.15% | 28 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $18 | $5.14 | +250.19% | 6 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 → $105 | $92.30 | +13.76% | 31 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 68.76 → CHF 64.71 | CHF 57.22 | +13.09% | 24 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 → $85 | $73.10 | +16.28% | 39 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $100 | $83.56 | +19.67% | 28 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $15.88 | +32.24% | 3 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $27 | $28.98 | -6.83% | 31 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $7 | $4.04 | +73.27% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $5 | $3.35 | +49.25% | 7 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $55 | $51.54 | +6.71% | 19 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8 | $4.43 | +80.59% | 20 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 → $160 | $155.39 | +2.97% | 26 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $80 | $65.70 | +21.77% | 20 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $55 | $39.78 | +38.28% | 3 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $125 → $115 | $98.83 | +16.36% | 20 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $27.38 | +9.57% | 5 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $53.59 | +86.60% | 1 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $155.00 | n/a | 1 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $175 | $93.75 | n/a | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $70 | $103.03 | n/a | 1 | Sep 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $0.7506 | n/a | 3 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 | $57.69 | n/a | 7 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $86 | $19.85 | n/a | 1 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $0.3694 | n/a | 1 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $18 | $10.76 | n/a | 8 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $0.0001 | n/a | 5 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $0.2653 | n/a | 7 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 → $95 | - | n/a | 4 | Mar 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 | $216.22 | n/a | 1 | Aug 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $97 | $11.16 | n/a | 1 | Aug 2, 2016 |
EDAP TMS
Jul 17, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $5.44
Upside: +175.74%
Boston Scientific
Jul 15, 2026
Maintained: Buy
Price Target: $70
Current: $44.62
Upside: +56.88%
DexCom
Jul 15, 2026
Maintained: Buy
Price Target: $85 → $90
Current: $77.98
Upside: +15.41%
Edwards Lifesciences
Jul 15, 2026
Maintained: Buy
Price Target: $100 → $105
Current: $87.84
Upside: +19.54%
Haemonetics
Jul 15, 2026
Maintained: Buy
Price Target: $85 → $90
Current: $78.50
Upside: +14.65%
Intuitive Surgical
Jul 15, 2026
Maintained: Hold
Price Target: $525 → $500
Current: $402.33
Upside: +24.28%
ResMed
Jul 15, 2026
Maintained: Buy
Price Target: $235 → $220
Current: $202.76
Upside: +8.50%
Teleflex
Jul 15, 2026
Maintained: Hold
Price Target: $140 → $145
Current: $135.22
Upside: +7.23%
Tandem Diabetes Care
Jul 15, 2026
Maintained: Hold
Price Target: $24 → $20
Current: $16.29
Upside: +22.77%
Lantheus Holdings
Jul 15, 2026
Maintained: Buy
Price Target: $115 → $120
Current: $105.11
Upside: +14.17%
Jul 15, 2026
Maintained: Buy
Price Target: $20 → $17
Current: $8.81
Upside: +92.96%
Jul 15, 2026
Maintained: Buy
Price Target: $90 → $95
Current: $81.79
Upside: +16.15%
Jul 15, 2026
Maintained: Buy
Price Target: $20 → $18
Current: $5.14
Upside: +250.19%
Jul 15, 2026
Maintained: Buy
Price Target: $100 → $105
Current: $92.30
Upside: +13.76%
Jul 15, 2026
Maintained: Buy
Price Target: CHF 68.76 → CHF 64.71
Current: CHF 57.22
Upside: +13.09%
Jun 3, 2026
Maintained: Buy
Price Target: $100 → $85
Current: $73.10
Upside: +16.28%
Jun 3, 2026
Maintained: Buy
Price Target: $120 → $100
Current: $83.56
Upside: +19.67%
Jun 3, 2026
Maintained: Buy
Price Target: $21
Current: $15.88
Upside: +32.24%
May 14, 2026
Maintained: Hold
Price Target: $22 → $27
Current: $28.98
Upside: -6.83%
May 7, 2026
Maintained: Buy
Price Target: $8 → $7
Current: $4.04
Upside: +73.27%
May 6, 2026
Maintained: Hold
Price Target: $12 → $5
Current: $3.35
Upside: +49.25%
May 5, 2026
Maintained: Buy
Price Target: $70 → $55
Current: $51.54
Upside: +6.71%
Apr 30, 2026
Maintained: Buy
Price Target: $10 → $8
Current: $4.43
Upside: +80.59%
Apr 30, 2026
Maintained: Buy
Price Target: $130 → $160
Current: $155.39
Upside: +2.97%
Apr 30, 2026
Maintained: Buy
Price Target: $90 → $80
Current: $65.70
Upside: +21.77%
Apr 29, 2026
Maintained: Buy
Price Target: $40 → $55
Current: $39.78
Upside: +38.28%
Apr 20, 2026
Maintained: Hold
Price Target: $125 → $115
Current: $98.83
Upside: +16.36%
Apr 13, 2026
Maintained: Buy
Price Target: $30
Current: $27.38
Upside: +9.57%
Apr 13, 2026
Maintained: Buy
Price Target: $100
Current: $53.59
Upside: +86.60%
Jun 13, 2025
Maintained: Buy
Price Target: $65
Current: $155.00
Upside: n/a
Nov 5, 2021
Maintained: Buy
Price Target: $175
Current: $93.75
Upside: n/a
Sep 16, 2021
Rated: Buy
Price Target: $70
Current: $103.03
Upside: n/a
Aug 11, 2021
Rated: Buy
Price Target: $20
Current: $0.7506
Upside: n/a
Aug 10, 2021
Rated: Buy
Price Target: $45
Current: $57.69
Upside: n/a
May 20, 2021
Rated: Buy
Price Target: $86
Current: $19.85
Upside: n/a
Sep 17, 2020
Initiated Coverage: Buy
Price Target: $15
Current: $0.3694
Upside: n/a
Aug 13, 2020
Maintained: Hold
Price Target: $25 → $18
Current: $10.76
Upside: n/a
Dec 3, 2019
Maintained: Buy
Price Target: $7
Current: $0.0001
Upside: n/a
Aug 17, 2018
Reiterated: Buy
Price Target: $7 → $6
Current: $0.2653
Upside: n/a
Mar 5, 2018
Reiterated: Hold
Price Target: $80 → $95
Current: -
Upside: n/a
Aug 25, 2017
Maintained: Buy
Price Target: $93
Current: $216.22
Upside: n/a
Aug 2, 2016
Reiterated: Hold
Price Target: $97
Current: $11.16
Upside: n/a